Trials / Completed
CompletedNCT04774185
Hearing Aid Transmitter Performance Study - SRF-366
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Sonova AG · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Sonova Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Sonova Hearing Systems undergo a final quality control in terms of clinical trials. This is a confirmatory study, investigating benefits of a modified hearing aid loudspeaker. This will be a clinical investigation which will be conducted mono centric at National Acoustic Laboratories a well known institution with exceptional experience (Australia).
Detailed description
In this study a comparison with two Phonak Receiver in Canal (RIC) devices is done. The experimental device with a modified hearing aid loudspeaker concept and the active comparator with the existing technology will be compared regarding speech intelligibility, listening effort and sound quality in speech in noise, quiet situations for people with mild to moderate hearing losses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | New hearing aid loudspeaker | The new hearing aid loudspeaker will be fitted to the participants individual ear anatomy and hearing loss. |
| DEVICE | Standard hearing aid loudspeaker | The standard hearing aid loudspeaker will be fitted to the participants individual ear anatomy and hearing loss. |
Timeline
- Start date
- 2021-04-26
- Primary completion
- 2022-04-25
- Completion
- 2022-04-25
- First posted
- 2021-03-01
- Last updated
- 2023-03-28
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04774185. Inclusion in this directory is not an endorsement.